Soligenix (SNGX) Cash from Operations (2010 - 2026)
Soligenix's (SNGX) quarterly Cash from Operations came in at 2357723.0 in Q1 2026, down 27.65% YoY from 3258803.72 in Q1 2025, and up 14.11% on a QoQ basis from 2745104.0 in Q4 2025.
Soligenix (SNGX) Cash from Operations (2010 - 2026) Analysis & Trends
Soligenix (SNGX) has 17 years of Cash from Operations data on file, last reported at 2357723.0 in Q1 2026.
- Quarterly Cash from Operations fell 27.65% year-over-year to 2357723.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10777264.0 (down 20.98% YoY) and the FY2025 annual result came in at 10266553.0, down 22.17% from the prior year.
- Cash from Operations climbed to 2357723.0 in Q1 2026, from 2745104.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1342482.0 in Q1 2024 to a low of 3627141.0 in Q4 2022.
- A 5-year average of 2487119.06 and a median of 2528060.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations slumped 52.39% — and 2023, when it soared 49.6%.
- Tracing SNGX's Cash from Operations over 5 years: stood at 3627141.0 in 2022, then surged by 49.6% to 1828213.0 in 2023, then slipped by 22.13% to 2232857.0 in 2024, then dropped by 22.94% to 2745104.0 in 2025, then climbed by 14.11% to 2357723.0 in 2026.
- The last three Cash from Operations figures came in at 2357723.0 (Q1 2026), 2745104.0 (Q4 2025), and 2932614.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - | -1.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.71 Mn |
| Jun 30, 2026 | -1.71 Mn |
| Mar 31, 2026 | -2.36 Mn |
| Mar 31, 2026 | -2.36 Mn |
| Dec 31, 2025 | -2.75 Mn |
| Dec 31, 2025 | -2.75 Mn |
| Sep 30, 2025 | -2.93 Mn |
| Sep 30, 2025 | -2.93 Mn |
| Jun 30, 2025 | -2.74 Mn |
| Jun 30, 2025 | -2.74 Mn |
| Mar 31, 2025 | -1.85 Mn |
| Mar 31, 2025 | -1.85 Mn |
| Dec 31, 2024 | -2.23 Mn |
| Dec 31, 2024 | -2.23 Mn |
| Sep 30, 2024 | -2.91 Mn |
| Sep 30, 2024 | -2.91 Mn |
| Jun 30, 2024 | -1.92 Mn |
| Jun 30, 2024 | -1.92 Mn |
| Mar 31, 2024 | -1.34 Mn |
| Mar 31, 2024 | -1.34 Mn |